JASVINDER SINGH to Antibodies, Monoclonal
This is a "connection" page, showing publications JASVINDER SINGH has written about Antibodies, Monoclonal.
Connection Strength
1.292
-
Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD008794.
Score: 0.151
-
Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2011 Jan; 38(1):10-20.
Score: 0.147
-
Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010 Jul 07; (7):CD008331.
Score: 0.144
-
Golimumab for rheumatoid arthritis: a systematic review. J Rheumatol. 2010 Jun; 37(6):1096-104.
Score: 0.143
-
Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010 Jan 20; (1):CD008341.
Score: 0.140
-
Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs. 2010; 70(2):121-45.
Score: 0.139
-
Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA). Joint Bone Spine. 2020 07; 87(4):307-313.
Score: 0.071
-
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019 01; 71(1):5-32.
Score: 0.065
-
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 05 08; 5:CD012657.
Score: 0.058
-
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Cochrane Database Syst Rev. 2016 11 17; 11:CD012437.
Score: 0.056
-
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2016 May 13; (5):CD012183.
Score: 0.054
-
Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. Immunotherapy. 2013 Mar; 5(3):265-99.
Score: 0.043
-
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ. 2009 Nov 24; 181(11):787-96.
Score: 0.034
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD007848.
Score: 0.034
-
TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015 Apr 18; (4):CD005468.
Score: 0.013